Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO1 to predict outcomes to anti-PD-1 in metastatic melanoma (MM).

Authors

null

Douglas Buckner Johnson

Vanderbilt University Ingram Cancer Center, Nashville, TN

Douglas Buckner Johnson , Jennifer Bordeaux , Ju Young Kim , Christine Vaupel , David L. Rimm , Thai Huu Ho , Richard Wayne Joseph , Adil Daud , Robert Martin Conry , Elizabeth M Gaughan , Anastasios Dimou , Justin M. Balko , James William Smithy , John S Witte , Svetlana B McKee , Nicole Dominiak , Bashar Dabbas , Jeff Hall , Naveen Dakappagari

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Biologic Correlates

Citation

J Clin Oncol 35, 2017 (suppl; abstr 9517)

DOI

10.1200/JCO.2017.35.15_suppl.9517

Abstract #

9517

Poster Bd #

125

Abstract Disclosures

Similar Posters

First Author: Mathilde Cancel

Poster

2021 Gastrointestinal Cancers Symposium

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

First Author: Marwan Fakih

First Author: Ines Esteves Domingues Pires Da Silva